bibliographic entry 7442085 [be/7442085]
https://w3id.org/oc/corpus/be/7442085

is a
content
  • San-Miguel, J, Bladé, J, Shpilberg, O, Grosicki, S, Maloisel, F, Min, C-K, Polo Zarzuela, M, Robak, T, Prasad, SVSS, Tee Goh, Y, Laubach, J, Spencer, A, Mateos, M-V, Palumbo, A, Puchalski, T, Reddy, M. Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma, Blood, 2014, 123, 4136, 4142, PMID: 24833354
references